MedTrace Logo

Assessment of the Health Improvement of Obese Patients After Fecal Microbiota Transplantation (FMT)

NCT04579263 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 2

Last updated 2020-10-08

No results posted yet for this study

Summary

Search for mechanisms of the effect of fecal microbiota transplantation on patients with obesity

Conditions

  • Obesity; Familial

Interventions

OTHER

Fecal microbiota

Transplantation of fecal microbiota of healthy donor with normal body mass index

Sponsors & Collaborators

  • Endocrinology Research Centre, Moscow

    collaborator OTHER_GOV

  • Federal Research and Clinical Center of Physical-Chemical Medicine

    lead OTHER

Principal Investigators

  • Elena Ilina, MD · Federal Research and Clinical Center of Physical-Chemical Medicine

  • Marina Shestakova, MD · Endocrinology Research Centre, Moscow

  • Elena Zhgun, PhD · Federal Research and Clinical Center of Physical-Chemical Medicine

  • Elena Pokrovskaya · Endocrinology Research Centre, Moscow

  • Igor Sklyanik · Endocrinology Research Centre, Moscow

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
40 Years
Max Age
50 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-02-15
Primary Completion
2020-08-15
Completion
2020-09-22

Countries

  • Russia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04579263 on ClinicalTrials.gov